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Aims We investigated the presence and clinical outcome of inducibility of atrial tachyarrhythmias after
circumferential pulmonary vein isolation (CPVI) in patients with paroxysmal atrial ﬁbrillation (PAF).
Methods and results Sixty patients with symptomatic PAF underwent CPVI guided by 3D mapping and
double Lasso technique. After achievement of CPVI, the induction was performed. The left atrium
(LA) volume and the isolated LA area around the right and left-sided pulmonary veins were measured
by the 3D mapping system. Sustained atrial tachyarrhythmias (.10 min) were induced after CPVI in
17 of 60 patients (28%). Patients with inducible atrial tachyarrhythmias had signiﬁcantly smaller isolated
areas when compared with the group with non-inducible tachyarrhythmias (16.7+2.3 vs. 18.8+2.9%,
P , 0.05). After the initial procedure, recurrence occurred in 18 of 43 (42%) patients in the non-indu-
cible group and in 7 of 17 (41%) in the inducible group during follow-up. A repeat procedure was per-
formed in all 25 patients with recurrence. Five patients had a recurrence after the repeat procedure
during 20.8+7.5 months, and there was no difference between the two groups.
Conclusion Inducibility of atrial tachyarrhythmias is associated with proportionally smaller isolated area
and does not predict the clinical efﬁcacy of CPVI in patients with PAF.
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Introduction
Previous studies have demonstrated that atrial ﬁbrillation
(AF) could be initiated by spontaneous focal discharges
originating from the pulmonary veins (PVs).
1 This import-
ant ﬁnding has led to the development of a smaller seg-
mental PV isolation (PVI) and a larger circumferential PVI
(CPVI) using continuous circular lesions (CCLs) around the
ipsilateral PVs.
2,3 The ablation approach has shifted from
segmental PVI to CPVI in clinical practice because CPVI is
m o r ee f f e c t i v et h a ns e g m e n t a lP V Ii np a t i e n t sw i t h
paroxysmal AF (PAF).
4,5 However, recurrence after the
initial procedure is still a major concern, and recent
studies have demonstrated that recovered PV conduction
after the initial PVI is a dominant factor of recurrent
atrial tachyarrhythmias in patients with PAF.
3,6 Further-
more, induction of AF after the PVI calls for aggressive
ablation with either additional linear lesions or ablation
of fractionated electrograms in the left atrium (LA) to
reduce clinical recurrence in patients with PAF,
7–10 but
inducible atrial tachyarrhythmias do not clinically recur
in many patients with inducibility after PVI.
8 There are
still limited data about inducibility after CPVI using our
approach in patients with PAF. This study prospectively
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outcome after CPVI in patients with PAF.
Methods
Patients
This prospective study included 60 consecutive patients (45 males;
58.3+10.4 years) with highly symptomatic PAF. Paroxysmal atrial
ﬁbrillation was deﬁned as AF lasting ,7 days and demonstrating
spontaneous termination and followed by sinus rhythm (SR) con-
ﬁrmed by ECG in 3 months before the catheter ablation. In the
initial procedure, all patients underwent only CPVI consisting of
two CCLs around the ipsilateral PVs guided by 3D electroanatomical
mapping and two Lasso catheters within the PVs.
Electrophysiological study
All patients provided written informed consent. All anti-arrhythmic
agents, except amiodarone (n ¼ 10), were stopped at least ﬁve drug
half-lives before the study. Oral anticoagulation was administered
(international normalized ratio 2–3 times) for at least 1 month,
and transoesophageal echocardiography was performed prior to
the procedure to exclude LA thrombus.
Inducibility was evaluated using 10 s burst pacing from the coron-
ary sinus (CS) at a maximum current output (20 mA: UHS20, Biotro-
nik Inc., Germany) starting at a cycle length of 250 ms decreasing
down to refractoriness.
8 Induction was tested ﬁve times before
and after the PVI. Sustained AF was deﬁned as AF lasting more
than 10 min.
8 Atrial ﬂutter (AFL) was conﬁrmed by the entrainment
study at the isthmus, including the cavotricuspid AFL (right AFL) or
left AFL involving the left isthmus between the mitral annulus and
the left inferior PV. Other regular tachycardia with a stable cycle
length recorded in the CS catheter and a constant P-wave mor-
phology was deﬁned as the atrial tachycardia (AT).
Left atrium mapping
The method of 3D electroanatomical mapping in the LA has been
described previously in detail.
2,11 Electrical and pharmacological
cardioversion were not attempted before complete isolation.
Mapping was performed with a 3.5 mm-tip catheter (ThermoCool
Navi-Star, Biosense Webster Inc., Diamond Bar, CA, USA) during SR
or AF using the CARTO mapping system (Biosense-Webster Inc.,
Diamond Bar, CA, USA). Mapping was complete when all regions of
the LA had been systematically sampled and when a sufﬁcient
density of points had been acquired to determine the LA chamber.
After reconstruction of the LA, each PV ostium identiﬁed by selec-
tive venography was tagged on the electroanatomical map. All
points inside PV were deleted. The volume of the LA chamber and
the LA surface area were automatically analysed by the CARTO
system. The isolated areas surrounding the left-sided and right-
sided PVs within CCLs (isolated area) were also measured by the
CARTO system. These measurements were performed by experi-
enced cardiologists independent of this study. The proportionally
isolated area was deﬁned as the value of both isolated area
divided by the whole LA area (proportionally isolated area ¼ iso-
lated area/LA area   100) (Figure 1).
Catheter ablation
Two decapolar Lasso catheters (Biosense Webster Inc., Diamond Bar,
CA, USA) were placed within the ipsilateral superior and inferior PVs
or within the superior and inferior branches of a common PV before
radiofrequency (RF) delivery. Irrigated RF energy was delivered as
described previously with a target temperature of 458C, a
maximal power of 30–40 W, and an infusion rate of 17 mL/min.
2 In
all patients, maximal power of 30 W was delivered to the posterior
wall to avoid a potential risk of LA-oesophageal ﬁstula. Radiofre-
quency ablation was initially performed to create the right-sided
CCLs and subsequently on the left-sided CCLs. These CCLs were
performed in the posterior wall  1 cm and in the anterior wall
 5 mm from the angiographically deﬁned PV ostia (Figure 1).
The endpoint of the CCLs was deﬁned as an absence of all PV
spikes documented with the two Lasso catheters within the ipsilat-
eral PVs at least 30 min after isolation. No linear lesions were
created, such as block of right cavo-tricuspid annulus or left
mitral isthmus.
Post-ablation care and follow-up
After the procedure, intravenous heparin was administered for 3
days in all patients, followed by warfarin for at least 3 months.
All patients were kept on the previously ineffective anti-arrhythmic
drugs for 1 month after ablation. Surface ECG, transthoracic echo-
cardiography, and 24 h Holter recording were performed 1 day
after the procedure and repeated after 1, 3, 6, 12, 18, and 24
months by the referring physician or the ablation centre. Recurrent
tachycardias included all tachycardia after the ﬁrst procedure
without any blanking period. The diagnosis of tachyarrhythmias
was deﬁned by 12 ECG or 24 h Holter recording.
Statistical analysis
All measured data are shown as the mean+standard deviation. The
unpaired t-test was used for comparisons between the two groups
corrected using the Tukey–Kramer analysis. Categorical variables
were compared by the x
2 analysis or with Fisher exact test when
appropriate. To determine the predictors of AF inducibility, vari-
ables entered into a multivariate logistic regression analysis. The
Kaplan–Meier analysis was used for the examination of the event-
free rate. Differences in arrhythmic event-free rate were assessed
by the log-rank test. A two-sided P , 0.05 was considered to indi-
cate statistical signiﬁcance. All statistical analyses were performed
using JMP Release 5.0 statistical software package (SAS Institute
Inc., Cary, NC, USA).
Results
Patient characteristics
The clinical characteristics are shown in Table 1. Atrial ﬁbril-
lation was ﬁrst diagnosed 62+56 months before referral
and had been ineffectively treated by a mean of 2.0+1.0
anti-arrhythmic drugs (ranged 1–5), including amiodarone
in 10 patients (16.7%). Structural heart diseases had been
diagnosed in nine (15%) patients. There were ﬁve patients
with coronary heart disease, two patients with dilated car-
diomyopathy, one patient with mitral valve replacement,
and one patient after atrial septal defect repair. A dual-
chamber pacemaker had been implanted in one patient.
Primary hypertension had been documented in 20 patients
(33%). The mean of the LA diameter was 43.0+5.6 mm.
Procedure outcome
The complete electrical isolation of all PVs was achieved in
all 60 patients. Mean procedure time was 198+57 min, RF
duration 42+8 min, and ﬂuoroscopy exposure time 21+
9 min. No complication occurred during and after the abla-
tion procedure.
Before ablation, AF spontaneously occurred or was
induced by the manipulation of the Lasso catheter or the
mapping catheter in the LA in 30 patients and was induced
by burst pacing after 3D mapping in 23 patients (non-
sustained AF in 12 and sustained AF in 11 patients). Spon-
taneous or induced AF was terminated before ablation in
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42 patients, including 7 patients without inducible AF and 35
patients with AF termination before ablation. In the remain-
ing 18 patients with long-lasting AF .30 min (13 patients
with spontaneous AF and 5 with induced AF), ablation was
performed during AF. In 9 out of these 18 patients (50%),
AF terminated before 2 CCLs in 7 patients and after 2 CCLs
in 2 patients. In 6 of these 18 patients (33.3%), AF converted
to cavo-tricuspid AFL in 3 patients and left atrial AFL in 3
patients. Atrial ﬁbrillation remained after complete PVI
and required electrical cardioversion in three patients
(16.7%).
Relationship between the inducibility test and
left atrium substrate
In 42 patients with ablation during SR, sustained AF was
inducible in 10 patients (23.8%) after complete PVI;
whereas AF was induced in 7 out of 18 patients (38.9%)
with ablation during AF (P ¼ 0.23). Surprisingly, sustained
AF was not inducible in two out of three patients in whom
electrical cardioversion was required to terminate AF after
CPVI.
After PVI, sustained atrial tachyarrhythmias were non-
inducible in 43 (71.7%, group I) patients and inducible in
17 patients (28.3%, group II). In group II, only AF was
induced in eight patients (13.3%); in the remaining nine
patients (15%), the induced tachyarrhythmias were
common-type AFL in six patients and left macro-re-entrant
AT in three patients.
Clinical characteristics of both groups of patients are
shown in Table 2. The age, gender, structural heart diseases,
the history of AF duration, LA dimension, administration of
amiodarone, and history of hypertension and structural
heart diseases showed no signiﬁcant difference between
the two groups. In contrast, patients from group II had a sig-
niﬁcantly larger LA volume and a relatively larger LA area
than that of group I (106.6+26.1 vs. 91.3+21.9 mL; P ,
0.05; 125.1+19.9 vs. 114.4+18.1 mm
2; P ¼ 0.059). Also,
the proportionally isolated areas around the right and left
ipsilateral PV were signiﬁcantly smaller in group II than in
group I after complete PVI (16.7+2.3 vs. 18.8+2.9%;
P , 0.05). On the basis of regression logistic analysis, the
proportionally isolated area is the only predictor for
Table 2 Comparison of clinical and electrophysiological
characteristics between inducible and non-inducible patients
Non-inducible
n ¼ 43
Inducible
n ¼ 17
P-value
Age (year) 57.7+10.4 59.8+10.8 0.4933
Gender (male/female) 32/11 13/4 0.8686
History of HT (%) 13 (32.5%) 7 (41.2%) 0.657
LAD (mm) 42.1+4.7 44.9+6.8 0.1188
Use of amiodarone (%) 5 (11.6) 5 (29.4) 0.0958
History of AF
duration (m)
59.9+68.4 48.4+40.8 0.5499
Structural heart
diseases (%)
6 (13.4%) 3 (17.7%) 0.7181
LA volume (mL) 91.3+21.9 106.6+26.1 0.0282
LA area (mm
2) 114.4+18.1 125.1+19.9 0.0590
Isolated PV area,
absolute (mm
2)
21.5+4.5 21.2+5.1 0.3287
Isolated LA area,
proportion (%)
18.8+2.9 16.9+2.3 0.0173
HT, hypertension; AF, atrial ﬁbrillation; LAD, left atrial dimension; LA,
left atrium; PV, pulmonary vein.
Figure 1 Three-dimensional anatomic map of the left atrium in the left lateral (LL; left panel), posteroanterior (PA; middle panel), and the
right lateral view (RL; right panel). Right and left continuous circular lesions are marked by multiple red dots around the pulmonary veins, and
the two sites with brown dots located in the right superior circular linear lesions and in the left anterior circular linear lesions indicate sim-
ultaneous isolation of the ipsilateral pulmonary vein when both circular linear lesions are complete. The bilateral blue areas surrounded by
circular lesions are the isolated pulmonary vein area. PV, pulmonary vein; LPV, left-sided PV; RPV, right-sided PV.
Table 1 Patients characteristics
Gender (male/female) 45/15
Age (year) 58.3+10.4
History of AF duration (m) 61.9+55.7
LAD (mm) 43.0+5.6
Structural heart diseases, n(%) 9 (15%)
History of HT, n(%) 20 (33.3%)
Amiodarone, n(%) 10 (16.7%)
AF, atrial ﬁbrillation; LAD, left atrial dimension; HT, hypertension.
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PVI (HR, 0.437; 95% CI, 0.212–0.898; P ¼ 0.0243).
Compared with nine patients with inducible AT or AFL,
eight patients with inducible AF had larger LA volume
(120+28 vs. 94+17 mL; P , 0.05) and LA surface area
(135+21 vs. 114+11 mm
2; P , 0.05).
Clinical outcome during follow-up
After the initial procedure, 18 of 43 patients (42%) from
group I and 7 of 17 patients (41%) from group II had recur-
rences at mean follow-up of 16.1+8.2 months. In 18
patients from group I, the clinical atrial tachyarrhythmias
were recurrent AF in 13 patients and new occurrence of AT
in 5 patients; whereas in 7 patients from group II, the clini-
cal atrial tachyarrhythmias after the PVI were recurrent AF
in 2 patients and new occurrence of regular AT in 5 patients.
Statistically, there seemed to be no difference in recurrence
after complete PVI between both groups by the Kaplan–
Meier analysis.
Repeat procedure after circumferential pulmonary
vein isolation
All of 25 patients with recurrent atrial tachyarrhythmias
after the initial PVI underwent a second ablation procedure.
In all of 25 patients, the recovered PV conduction was
found. All conduction gaps on the CCLs were easily identiﬁed
by using two Lasso catheters within the ipsilateral PVs and
were successfully closed with a few irrigated RF applications
in all 25 patients. All Macro-ATs were successfully ablated
with a linear lesion across the isthmus in four patients.
After the second procedure, AF occurred in 5 out of 25
patients (4 patients from group I and 1 from group II).
Stable SR was maintained in 55 patients during 20.8+7.5
months. The success rate was not signiﬁcantly different
between the two groups after the second ablation procedure
(91% in group I and 94% in group II) (Figure 2).
Discussion
Major ﬁndings
This report demonstrates that (i) inducibility of atrial
tachyarrhythmias after CPVI is associated only with the
size of proportionally isolated LA area and (ii) it is most
likely that inducibility after CPVI cannot predict clinical
atrial tachyarrhythmias recurrence during follow-up in
patients with PAF and nearly normal hearts.
Previous studies on atrial ﬁbrillation inducibility
after pulmonary vein isolation
Previous studies have demonstrated that non-inducibility of
sustained AF after PVI associated with lower recurrence
rates and a better clinical outcome.
7–9,12,13 Additional
linear lesions in the LA isthmus or LA roof line after PVI
can reduce inducibility
8 and improve success rate in the
follow-up after PVI.
14,15 A ‘step-wise approach’ was associ-
ated with a signiﬁcantly lower recurrence rate of 13 vs.
38% in patients with sustained or persisting AF during long-
term follow-up.
8 Oral et al. described an ablation approach
based on non-inducibility of AF in patients with circumferen-
tial PVablation and linear lesions in the posterior and lateral
LA. After the ﬁrst lesion, this study randomized the patients
to no further ablation or electrogram-guided ablation in the
LA targeting non-inducibility. After a 6-month follow-up,
33% of the patients with inducible AF and no additional abla-
tion and 14% of the patients who were rendered non-
inducible had recurrent arrhythmia.
9
Several studies have shown that inducibility of AF could be
preferred as an endpoint for ablation of PAF. However, each
study was based on a different protocol for the induction
test, such as the type of stimulation and the deﬁnition of
AF. Also some different ablation strategies were used; seg-
mental PVI, CPVI including atrial tissue, or modiﬁcation of
the atrial substrate required maintaining AF regardless of
PVI. Importantly, recent observations have shown that the
arrhythmic substrate in PAF is localized in the PV or the
atrial tissue around the PV, so-called ‘PV antrum’ in PAF.
12
This can give a strong support why CPVI have a better
outcome in PAF.
Inducibility after circumferential pulmonary
vein isolation
In the present study, we showed that (i) inducibility of AF
or other AT after CPVI was frequent in patients with
larger LA volume and proportionally smaller isolated
areas surrounding PV and (ii) the induction of atrial
tachyarrhythmias after CPVI resulted in a relative lower
incidence (28%) when compared with the previous studies
(43–60%). The CCLs surrounding the PV in our procedure
are larger than the lesions of segmental PVI and include
the atrial tissue around the PV. The endpoint of our pro-
cedure is complete isolation of the PV. This may result in
the elimination of some random re-entry outside the PV
ostium that drives AF. The larger circumferential lesion
may contribute to the lower incidence of inducibility in
our study. A recent study described a better prognosis
after PVI with CCLs with larger isolated area than segmen-
tal ostial ablation in patients with AF, and this outcome
supports our results.
5
Atrial ﬁbrillation inducibility and clinical outcome
after circumferential pulmonary vein isolation
There are few reports to show that the inducibility is not
associated with the recurrence in patients with PAF. In our
report, all 25 patients who received the second procedure
for recurrent tachycardia showed recovered PV conduction.
After the closure of the conduction gap and ablation of AT
circuits, 91% of the patients from group I and 94% from
group II maintained SR, and the recurrence rate showed no
signiﬁcant difference between the inducible and the non-
inducible group after the second procedure in this study.
Recovered conduction across previously disconnected PVs
has been observed as one of the dominant factors in patients
undergoing repeat ablation for recurrent AF.
2,3,6,16,17 These
observations suggest that the substrate of AF consisting of
trigger and maintenance is localized in the PV and/or the
LA tissue surrounding the PV in most patients with PAF.
The most critical issue in PVI is that recovered conduction
across CCLs was not possible to predict at the initial ablation
procedure.
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tachycardia/atrial ﬂutter
Interestingly, inducibility of regular tachycardias (ATor AFL)
after CPVI also did not correlate with recurrence of AT/AFL.
The positive and negative predictive values were 33.3 and
88.3% of the induction test for AT/AFL recurrence. The nega-
tive predictive value for recurrence of AF was 69.8%. Left
atrium volume and LA area were signiﬁcantly larger in
patients with inducible AF, compared with patients with
inducible AT or AFL and non-inducible patients. These data
suggested that (i) non-inducibility of AT/AFL might be a
better predictor for no recurrence of AT/AFL than that of
AF and (ii) more diseased atrium might contribute to the
inducibility of AF. However, our previous observation also
showed that even regular AT developed with the recovered
conduction of PV, as a role of trigger of tachycardia.
3 In
clinical practice, it is very difﬁculty to create conduction
block over the left isthmus.
18 An incomplete linear lesion
is a potential risk factor for the recurrence of AT/AFL.
19
The permanent disconnection of PVs can achieve long-term
success in patients with PAF regardless of the inducibility of
AF, and it remains associated with AF cure in patients
treated with PVI.
3,6 On the basis of our observations,
additional linear ablation in the LA may be unnecessary
except in patients with clinically suggested LA
macro-re-entrant tachycardia.
Study limitations
There were several limitations in the study. First, induced AF
was manipulated by the Lasso or mapping catheter within
the PVs in 30 patients before ablation. Electrophysiologi-
cally, it may be different from that of burst pacing. Also,
it was almost impossible to induce AF from the PVafter abla-
tion. Secondly, in this study, sustained atrial tachyarrhyth-
mias were deﬁned more than 10 min before ablation. This
may result in a different incidence of inducibility after
CPVI if the sustained AF deﬁnition was used as ,10 min.
Thirdly, no computed tomography or magnetic resonance
image was used before ablation. Therefore, the CARTO-
based calculation of LA area and isolated areas may be
inappropriate due to different PV size in the isolated
areas. Fourthly, routine surface ECG and multiple 24 h
Holter ECG were used to identify asymptomatic recurrence
of AF, it might have been clinically missed. Finally, the
study population was relatively small. Further evaluation
with increasing number of patients may be required.
Conclusions
The patients with inducible atrial tachyarrhythmias have a
proportionally smaller isolated area after CPVI for PAF.
Importantly, inducibility after CPVI cannot predict the clini-
cal outcome in patients with PAF and nearly normal hearts.
These data provide new clinical information that additional
ablation with linear lesions or ablation of fractionated
potentials in the LA may be unnecessary in patients with
inducible atrial tachyarrhythmias after CPVI.
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